Search

everythinglearnresearchcommunity

for

Search:↓

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

People with alopecia areata may have a higher risk of blood clots.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Ruxolitinib can cause a delayed skin reaction on the nose.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.